Loading…

Recurrence of kala‐azar after PKDL: role of co‐factors

Recurrence of kala‐azar after post kala‐azar dermal leishmaniasis (PKDL) has remained uncommon. We report here two patients with recurrence of kala‐azar (KA) after development of PKDL. In one case the second attack of KA was preceded by repeated attacks of malaria and tuberculosis, and in the other...

Full description

Saved in:
Bibliographic Details
Published in:Tropical medicine & international health 1998-01, Vol.3 (1), p.76-78
Main Authors: Nandy, A., Addy, M., Maji, A. K., Guha, S. K., Banerjee, D., Chaudhuri, D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4426-167b05a635e1ee0522980683d798167208d42221db4698aa840776108ec0cca33
cites cdi_FETCH-LOGICAL-c4426-167b05a635e1ee0522980683d798167208d42221db4698aa840776108ec0cca33
container_end_page 78
container_issue 1
container_start_page 76
container_title Tropical medicine & international health
container_volume 3
creator Nandy, A.
Addy, M.
Maji, A. K.
Guha, S. K.
Banerjee, D.
Chaudhuri, D.
description Recurrence of kala‐azar after post kala‐azar dermal leishmaniasis (PKDL) has remained uncommon. We report here two patients with recurrence of kala‐azar (KA) after development of PKDL. In one case the second attack of KA was preceded by repeated attacks of malaria and tuberculosis, and in the other the recurrence of KA followed an attack of measles. While measles has earlier been suggested as co‐factor in inducing transformation from sub‐clinical to clinical kala‐azar, malaria was demonstrated to enhance the virulence and invasiveness of Leishmania in an experimental model as well as under natural condition. We propose that in our cases, measles and repeated attacks of malaria or tuberculosis led to immunosuppression and recurrence of visceral leishmaniasis (VL).
doi_str_mv 10.1046/j.1365-3156.1998.00176.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79703426</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79703426</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4426-167b05a635e1ee0522980683d798167208d42221db4698aa840776108ec0cca33</originalsourceid><addsrcrecordid>eNqNkMtKw0AUhgdRqlYfQchC3CWeuWQuxY3UW7GiSF0P08kEUtOmzjTYuvIRfEafxKQtXbs6B77_nB8-hCIMCQbGLycJpjyNKU55gpWSCQAWPFnuoaMd2F_vEBMi-CE6DmECAIylvIM6ikmmBDtCvVdna-_dzLqoyqN3U5rf7x_zZXxk8oXz0cvjzbAX-apcc1s1NDd2Uflwgg5yUwZ3up1d9HZ3O-o_xMPn-0H_ehhbxgiPMRdjSA2nqcPOQUqIksAlzYSSDSMgM0YIwdmYcSWNkQyE4Biks2CtobSLLjZ_5776qF1Y6GkRrCtLM3NVHbRQAmjT1ATlJmh9FYJ3uZ77Ymr8SmPQrTY90a0d3drRrTa91qaXzenZtqMeT122O9x6avj5lptgTZl7M7NF2MUIpkoq0sSuNrHPonSrf9fr0dOgWegfsEWGog</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79703426</pqid></control><display><type>article</type><title>Recurrence of kala‐azar after PKDL: role of co‐factors</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Nandy, A. ; Addy, M. ; Maji, A. K. ; Guha, S. K. ; Banerjee, D. ; Chaudhuri, D.</creator><creatorcontrib>Nandy, A. ; Addy, M. ; Maji, A. K. ; Guha, S. K. ; Banerjee, D. ; Chaudhuri, D.</creatorcontrib><description>Recurrence of kala‐azar after post kala‐azar dermal leishmaniasis (PKDL) has remained uncommon. We report here two patients with recurrence of kala‐azar (KA) after development of PKDL. In one case the second attack of KA was preceded by repeated attacks of malaria and tuberculosis, and in the other the recurrence of KA followed an attack of measles. While measles has earlier been suggested as co‐factor in inducing transformation from sub‐clinical to clinical kala‐azar, malaria was demonstrated to enhance the virulence and invasiveness of Leishmania in an experimental model as well as under natural condition. We propose that in our cases, measles and repeated attacks of malaria or tuberculosis led to immunosuppression and recurrence of visceral leishmaniasis (VL).</description><identifier>ISSN: 1360-2276</identifier><identifier>EISSN: 1365-3156</identifier><identifier>DOI: 10.1046/j.1365-3156.1998.00176.x</identifier><identifier>PMID: 9484974</identifier><language>eng</language><publisher>Oxford BSL: Blackwell Science Ltd</publisher><subject>Adolescent ; Biological and medical sciences ; Child ; co‐factors ; Human protozoal diseases ; Humans ; Immune Tolerance ; Infectious diseases ; Leishmaniasis, Cutaneous - complications ; Leishmaniasis, Cutaneous - etiology ; Leishmaniasis, Visceral - complications ; Leishmaniasis, Visceral - etiology ; Leishmaniasis, Visceral - immunology ; Leshmaniasis ; Malaria, Vivax - complications ; Malaria, Vivax - immunology ; Male ; Measles - complications ; Measles - immunology ; Medical sciences ; Parasitic diseases ; PKDL ; Protozoal diseases ; Recurrence ; recurrent kala‐azar ; re‐visceralization ; Tropical medicine ; Tuberculosis, Lymph Node - complications ; Tuberculosis, Lymph Node - immunology ; Tuberculosis, Pulmonary - complications ; Tuberculosis, Pulmonary - immunology</subject><ispartof>Tropical medicine &amp; international health, 1998-01, Vol.3 (1), p.76-78</ispartof><rights>1997 Blackwell Science Ltd</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4426-167b05a635e1ee0522980683d798167208d42221db4698aa840776108ec0cca33</citedby><cites>FETCH-LOGICAL-c4426-167b05a635e1ee0522980683d798167208d42221db4698aa840776108ec0cca33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2139892$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9484974$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nandy, A.</creatorcontrib><creatorcontrib>Addy, M.</creatorcontrib><creatorcontrib>Maji, A. K.</creatorcontrib><creatorcontrib>Guha, S. K.</creatorcontrib><creatorcontrib>Banerjee, D.</creatorcontrib><creatorcontrib>Chaudhuri, D.</creatorcontrib><title>Recurrence of kala‐azar after PKDL: role of co‐factors</title><title>Tropical medicine &amp; international health</title><addtitle>Trop Med Int Health</addtitle><description>Recurrence of kala‐azar after post kala‐azar dermal leishmaniasis (PKDL) has remained uncommon. We report here two patients with recurrence of kala‐azar (KA) after development of PKDL. In one case the second attack of KA was preceded by repeated attacks of malaria and tuberculosis, and in the other the recurrence of KA followed an attack of measles. While measles has earlier been suggested as co‐factor in inducing transformation from sub‐clinical to clinical kala‐azar, malaria was demonstrated to enhance the virulence and invasiveness of Leishmania in an experimental model as well as under natural condition. We propose that in our cases, measles and repeated attacks of malaria or tuberculosis led to immunosuppression and recurrence of visceral leishmaniasis (VL).</description><subject>Adolescent</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>co‐factors</subject><subject>Human protozoal diseases</subject><subject>Humans</subject><subject>Immune Tolerance</subject><subject>Infectious diseases</subject><subject>Leishmaniasis, Cutaneous - complications</subject><subject>Leishmaniasis, Cutaneous - etiology</subject><subject>Leishmaniasis, Visceral - complications</subject><subject>Leishmaniasis, Visceral - etiology</subject><subject>Leishmaniasis, Visceral - immunology</subject><subject>Leshmaniasis</subject><subject>Malaria, Vivax - complications</subject><subject>Malaria, Vivax - immunology</subject><subject>Male</subject><subject>Measles - complications</subject><subject>Measles - immunology</subject><subject>Medical sciences</subject><subject>Parasitic diseases</subject><subject>PKDL</subject><subject>Protozoal diseases</subject><subject>Recurrence</subject><subject>recurrent kala‐azar</subject><subject>re‐visceralization</subject><subject>Tropical medicine</subject><subject>Tuberculosis, Lymph Node - complications</subject><subject>Tuberculosis, Lymph Node - immunology</subject><subject>Tuberculosis, Pulmonary - complications</subject><subject>Tuberculosis, Pulmonary - immunology</subject><issn>1360-2276</issn><issn>1365-3156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqNkMtKw0AUhgdRqlYfQchC3CWeuWQuxY3UW7GiSF0P08kEUtOmzjTYuvIRfEafxKQtXbs6B77_nB8-hCIMCQbGLycJpjyNKU55gpWSCQAWPFnuoaMd2F_vEBMi-CE6DmECAIylvIM6ikmmBDtCvVdna-_dzLqoyqN3U5rf7x_zZXxk8oXz0cvjzbAX-apcc1s1NDd2Uflwgg5yUwZ3up1d9HZ3O-o_xMPn-0H_ehhbxgiPMRdjSA2nqcPOQUqIksAlzYSSDSMgM0YIwdmYcSWNkQyE4Biks2CtobSLLjZ_5776qF1Y6GkRrCtLM3NVHbRQAmjT1ATlJmh9FYJ3uZ77Ymr8SmPQrTY90a0d3drRrTa91qaXzenZtqMeT122O9x6avj5lptgTZl7M7NF2MUIpkoq0sSuNrHPonSrf9fr0dOgWegfsEWGog</recordid><startdate>199801</startdate><enddate>199801</enddate><creator>Nandy, A.</creator><creator>Addy, M.</creator><creator>Maji, A. K.</creator><creator>Guha, S. K.</creator><creator>Banerjee, D.</creator><creator>Chaudhuri, D.</creator><general>Blackwell Science Ltd</general><general>Blackwell Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199801</creationdate><title>Recurrence of kala‐azar after PKDL: role of co‐factors</title><author>Nandy, A. ; Addy, M. ; Maji, A. K. ; Guha, S. K. ; Banerjee, D. ; Chaudhuri, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4426-167b05a635e1ee0522980683d798167208d42221db4698aa840776108ec0cca33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adolescent</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>co‐factors</topic><topic>Human protozoal diseases</topic><topic>Humans</topic><topic>Immune Tolerance</topic><topic>Infectious diseases</topic><topic>Leishmaniasis, Cutaneous - complications</topic><topic>Leishmaniasis, Cutaneous - etiology</topic><topic>Leishmaniasis, Visceral - complications</topic><topic>Leishmaniasis, Visceral - etiology</topic><topic>Leishmaniasis, Visceral - immunology</topic><topic>Leshmaniasis</topic><topic>Malaria, Vivax - complications</topic><topic>Malaria, Vivax - immunology</topic><topic>Male</topic><topic>Measles - complications</topic><topic>Measles - immunology</topic><topic>Medical sciences</topic><topic>Parasitic diseases</topic><topic>PKDL</topic><topic>Protozoal diseases</topic><topic>Recurrence</topic><topic>recurrent kala‐azar</topic><topic>re‐visceralization</topic><topic>Tropical medicine</topic><topic>Tuberculosis, Lymph Node - complications</topic><topic>Tuberculosis, Lymph Node - immunology</topic><topic>Tuberculosis, Pulmonary - complications</topic><topic>Tuberculosis, Pulmonary - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nandy, A.</creatorcontrib><creatorcontrib>Addy, M.</creatorcontrib><creatorcontrib>Maji, A. K.</creatorcontrib><creatorcontrib>Guha, S. K.</creatorcontrib><creatorcontrib>Banerjee, D.</creatorcontrib><creatorcontrib>Chaudhuri, D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Tropical medicine &amp; international health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nandy, A.</au><au>Addy, M.</au><au>Maji, A. K.</au><au>Guha, S. K.</au><au>Banerjee, D.</au><au>Chaudhuri, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recurrence of kala‐azar after PKDL: role of co‐factors</atitle><jtitle>Tropical medicine &amp; international health</jtitle><addtitle>Trop Med Int Health</addtitle><date>1998-01</date><risdate>1998</risdate><volume>3</volume><issue>1</issue><spage>76</spage><epage>78</epage><pages>76-78</pages><issn>1360-2276</issn><eissn>1365-3156</eissn><abstract>Recurrence of kala‐azar after post kala‐azar dermal leishmaniasis (PKDL) has remained uncommon. We report here two patients with recurrence of kala‐azar (KA) after development of PKDL. In one case the second attack of KA was preceded by repeated attacks of malaria and tuberculosis, and in the other the recurrence of KA followed an attack of measles. While measles has earlier been suggested as co‐factor in inducing transformation from sub‐clinical to clinical kala‐azar, malaria was demonstrated to enhance the virulence and invasiveness of Leishmania in an experimental model as well as under natural condition. We propose that in our cases, measles and repeated attacks of malaria or tuberculosis led to immunosuppression and recurrence of visceral leishmaniasis (VL).</abstract><cop>Oxford BSL</cop><pub>Blackwell Science Ltd</pub><pmid>9484974</pmid><doi>10.1046/j.1365-3156.1998.00176.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1360-2276
ispartof Tropical medicine & international health, 1998-01, Vol.3 (1), p.76-78
issn 1360-2276
1365-3156
language eng
recordid cdi_proquest_miscellaneous_79703426
source Wiley-Blackwell Read & Publish Collection
subjects Adolescent
Biological and medical sciences
Child
co‐factors
Human protozoal diseases
Humans
Immune Tolerance
Infectious diseases
Leishmaniasis, Cutaneous - complications
Leishmaniasis, Cutaneous - etiology
Leishmaniasis, Visceral - complications
Leishmaniasis, Visceral - etiology
Leishmaniasis, Visceral - immunology
Leshmaniasis
Malaria, Vivax - complications
Malaria, Vivax - immunology
Male
Measles - complications
Measles - immunology
Medical sciences
Parasitic diseases
PKDL
Protozoal diseases
Recurrence
recurrent kala‐azar
re‐visceralization
Tropical medicine
Tuberculosis, Lymph Node - complications
Tuberculosis, Lymph Node - immunology
Tuberculosis, Pulmonary - complications
Tuberculosis, Pulmonary - immunology
title Recurrence of kala‐azar after PKDL: role of co‐factors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A43%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recurrence%20of%20kala%E2%80%90azar%20after%20PKDL:%20role%20of%20co%E2%80%90factors&rft.jtitle=Tropical%20medicine%20&%20international%20health&rft.au=Nandy,%20A.&rft.date=1998-01&rft.volume=3&rft.issue=1&rft.spage=76&rft.epage=78&rft.pages=76-78&rft.issn=1360-2276&rft.eissn=1365-3156&rft_id=info:doi/10.1046/j.1365-3156.1998.00176.x&rft_dat=%3Cproquest_cross%3E79703426%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4426-167b05a635e1ee0522980683d798167208d42221db4698aa840776108ec0cca33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79703426&rft_id=info:pmid/9484974&rfr_iscdi=true